Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Acrivon Therapeutics, Inc. (ACRV) had Free Cash Flow per Share of $-0.53 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-19.04M |
|
-- |
|
-- |
|
$19.90M |
|
$-19.90M |
|
$0.86M |
|
$-19.04M |
|
$-19.04M |
|
$-19.04M |
|
$-19.04M |
|
$-19.04M |
|
$-19.04M |
|
$-19.90M |
|
$-19.36M |
|
38.72M |
|
38.72M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$99.22M |
|
$4.65M |
|
$8.61M |
|
$107.83M |
|
$11.05M |
|
-- |
|
$1.26M |
|
$12.32M |
|
$95.52M |
|
$95.52M |
|
$95.52M |
|
38.74M |
|
| Cash Flow Statement Financials | |
$-20.54M |
|
$13.13M |
|
$-0.03M |
|
$41.70M |
|
$34.26M |
|
$-7.44M |
|
$2.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.94% |
|
-19.94% |
|
-17.66% |
|
-19.94% |
|
$2.47 |
|
|
Free Cash Flow per Share |
$-0.53 |
$-0.53 |
|